An alternative cause of OTX2 expression in these tumors would be that OTX2 is upregulated over the course of transformation through the acquisition of developmental or novel regulatory regions, as recently described for breast cancer or T-cell leukemia [36]. The gene discussed is OTX2; the disease is T-cell leukemia.